All Companies
Ticker LBPH
This stock is no longer actively trading
You reached the page — here's exactly what LBPH is, and why it's out of scope for now.
What this ticker is
LBPH
Longboard Pharmaceuticals, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $2.3B
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted